Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

Key drivers include technological advancements and evolving healthcare policies. The global market for short-acting insulin ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

DelveInsight's Short-Acting Insulin Market Insights report provides the current and forecast market analysis, individual ...

Insulin icodec is an acylated insulin analogue that makes it bind strongly to albumin in the body and have reduced affinity for insulin receptors, effectively creating an inactive reservoir that ...

If you've recently received a diagnosis of type 2 diabetes, understanding your treatment options is an important first step.

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

What Is an Insulin Resistance Diet? When it comes to preventing diabetes, your diet can make a big difference. And if you already have the condition, a diet change may help you manage it better.

Akero Therapeutics has a solid cash runway and financial stability to support ongoing trials for its drug candidate. Read ...

“The health ministry ensures patients get adequate treatment including increased use of an insulin analogue inhibitor,” he said. Dzulkefly had also attached a statement from the ministry in ...

Insulin can be a critical part of managing diabetes, but patients may not know all the ins and outs of using the medication effectively. Luckily, the American Diabetes Association (ADA) has plenty ...